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The most frequent childhood hepatic tumors are infantile hemangioendothelioma (IHE), cavernous hemangioma, mesenchymal hamt
artoma, hepatoblastoma, hepatocellular carcinoma, 
and rarely, benign or malignant germ cell tumors.1 IHE 
is the most common vascular tumor in childhood, act
counting for 12% of all childhood hepatic tumors, with 
most of the lesions being diagnosed in the first months 
of life. Spontaneous regression is expected in some cast
es. The differentiation between tumors that will regress 
and malignant tumors is not possible at present.2
CASE 
An 8tmonthtold female presented with abdominal ent
largement that had been noticed by the mother for 3 
months, and was associated with lowtgrade fever, loss 
of weight and mild respiratory distress. On examinat
tion, there was no jaundice, or pallor. Skin examination 
revealed a small purplish hemangioma over the anterior 
chest wall which was about 1.5×1 cm, firm, mobile and 
nontender. Cardiac and chest examinations were nort
mal. The abdomen was diffusely enlarged. The span of 
liver right lobe was about 14 cm, and it was firm, nont
tender and with smooth surface. There was no splenot
megaly nor ascites.
 The alpha fetoprotein of 13.88 ng/mL was cont
sidered high compared with the adult reference value 
(up to 10.9 ng/mL), but was found to be normal when 
adjusted to the age of the patient (8.5±5.5 ng/mL for 
8 months old) (Table 1). Abdominal ultrasonography 
revealed an enlarged liver with multifocal hypoechoic 
welltdefined lesions scattered all over the liver. Doppler 
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infantile hemangioendothelioma is a rare benign vascular tumor of the liver. We report a case of hepatic 
hemangioendothelioma in an 8- month-old female infant who presented with hepatomegaly and respi-
ratory distress, which was successfully treated with oral prednisolone for six months.
examination showed a patent portal vein (5.7 mm) with 
no evidence of portal hypertension. CT of the abdomen 
revealed variable size hypodense nodules with enhancet
ment arterial phase (Figure 1a, 1b) and with progressive 
centripetal filling in portal phase. A liver biopsy was not 
done for fear of hemorrhage. 
After one month of follow up without therapy, there 
was progressive hepatomegaly and respiratory distress 
with enlargement of the previously described masses 
detected by serial ultrasonography. She was treated 
with oral prednisolone, according to regimen used in 
similar case report.3 It was started with a dose of 4 mg/
kg/day in 2 divided doses for 2 weeks, then tapered to 4 
mg/kg/day on alternate days for 2 weeks. It was further 
tapered to 2 mg/kg on alternate days for 6 weeks and 1 
mg/kg on alternate days for 3 months. During the pet
riod of treatment, our patient had normal blood glucose 
and blood pressure with no side effects of steroids after 
6 months follow up. 
After treatment, there was a marked reduction in 
the abdominal enlargement, and the liver span was nort
mal (about 7 cm). Posttcontrast CT of the abdomen 
showed a marked reduction of the liver nodules (Figure 
2). However, the skin hemangioma did not disappear 
and the patient was referred to plastic surgery. 
DISCuSSION
IHE, the most common benign tumor of the liver in 
children, is seen almost exclusively (86%) in the first 6 
months of life, with about one third of the cases pret
senting in the first month. It is rare in children over 3 
years old. Girls are more frequently affected (1.7:1) and 
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Table 1. results of laboratory tests.
   Investigation Patient value Reference value
   Hemoglobin
   White blood cell count
   Platelet count 
7.5
14.6
529
12.5-15 gm/dL
5-11×109/L
150-450×109/L
   Serum albumin
   Serum Bilirubin
   aspartate aminotransferase
   alanine aminotransferase
4.7
0.9
64
48
3.-5.4 mg/dL
Up to 1 mg/dL
Up to 40 U/L
Up to 45 U/L
   Prothrombin time 
   activated partial thromboplastin time 
   international normalized ratio
12.9
52
1.1
10-12 seconds
25-38 seconds
0.9-1.2
   alpha fetoprotein 10.88            8.5±5.5 ng/ml
   VMa/HVa normal
VMa/HVa: Vanilyl mandelic acid/homovanelic acid
there is no racial predilection.4 
Clinical presentation usually involves an enlarged abt
domen noted by a parent, although about 10% to 15% 
of cases present with features of congestive heart failure, 
including high cardiac output, elevated right and left 
endtdiastolic pressure, a small systolic pressure gradient 
across the pulmonary outflow tract, and mildly elevated 
artery pressure.5 Less frequently, symptoms include 
jaundice (20% of cases), failure to thrive, fever, and, 
rarely, liver failure or tumor rupture.4 Hemangiomas 
at other sites, including the skin, lung, lymph nodes, 
pancreas, retroperitoneum, and bone are seen in 10% 
to 15% of cases. The most frequently involved site is the 
skin, where single or multiple lesions may be present.4 
IHE appears in solitary or (seldom) multiple form 
and may reach a size of some 15 cm. The unencapsut
lated tumor foci have blurred boundaries. They are 
spongetlike and reddish brown in color, but may bet
come firm and grey in bigger tumors.4 Hemoglobin 
levels are decreased below 10 mg/dL in about 50% of 
cases, asparate aminotransferase is elevated above 100 
U/L in 32%, and bilirubin is increased in 20%.4 Alphat
fetoprotein is not elevated when adjusted for the age of 
the child. Normal levels of alphatfetoprotein in neot
nates may be as high as 2500 ng/mL and the adult level 
of less than 25 ng/mL is not reached until 6 months 
of age.6
Plain xtray may show hepatomegaly or an upper 
abdominal mass, which may have punctuate or speckt
led calcification of the lesion in 15% to 37% of cases.7t9 
Cardiomegaly with or without prominent pulmonary 
vascular markings may be seen in infants with congest
tive heart failure.10 Ultrasonography may show solitary 
or multiple lesions, discrete or diffuse, with variable 
Figure 1a. CT of the abdomen showing variable size hypodense 
nodules.
Figure 1b. Post-contrast CT of the abdomen showing nodular 
enhancement arterial phase.
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echottexture.11t13 A CT scan gives the exact size and 
spread of the lesion. In noncontrast scans, the lesions 
are solitary or multiple, homogenous or nonthomoget
nous, with or without calcifications. Following contrast 
administration, there is early massive enhancement, 
which is either diffuse or peripheral.14
IHE should be included in the differential diagnosis 
of other hepatic masses developing in infancy, such as 
cavernous hemangioma, hepatoblastoma, and mesent
chymal hamartoma.15 Cavernous hemangioma rarely 
presents in infancy. It is the most common primary liver 
tumor in the older age group and is usually associated 
with other hemangiomas in the body. It rarely presents 
with congestive cardiac failure. Hepatoblastoma is the 
most common symptomatic malignant tumor presentt
ing before the age of 5 years. It may be single or mult
tiple and commonly involves the right lobe of the liver. 
The child commonly presents with an abdominal mass 
and is severely ill with weight loss, anorexia, pallor and 
weakness. The alphatfetoprotein and human chorionic 
gonadotropin levels are usually elevated. Mesenchymal 
hamartoma is a developmental anomaly rather than a 
true neoplasm. Usually, the patient presents with abt
dominal distension, fever, vomiting and constipation. 
The alphatfetoprotein levels are within normal limits. 
Plain films show a soft tissue mass. Ultrasonography, 
CT and magnetic resonance (MR) imaging show a 
predominantly cystic mass with multiple echogenic 
septae.15
The management of IHE and hemangiomas is cont
troversial.16 The severity of the presenting symptoms 
determines the approach to therapy. Most asymptomt
atic lesions can be managed expectantly, using serial 
ultrasound to visualize the anticipated spontaneous 
regression.1,2 In cases with a gradual onset of controlt
lable symptoms, the use of digitalis and diuretics for 
congestive heart failure, and the administration of 
blood products to correct anemia and coagulopathy 
can occasionally be sufficient. This can be accompanied 
by steroid therapy in an attempt to suppress continued 
growth of the lesion or even encourage regression.16
Relatively small solitary tumors are best treated by 
complete resection, which is often impossible and opt
eration is risky. Therefore, various conservative treatt
ments such as radiotherapy,17 hepatic artery ligation 
or embolization18,19 have been used. There have been 
several reports of orthotopic liver transplantation for 
massive, uncontrollable IHE. Apart from the young age 
of the patients and the urgency of the situation, there 
are major logistical problems, and the results in the few 
reported cases have not been good enough to propose 
orthotopic liver transplantation as a standard procet
dure in the treatment of large IHE.5 However, it was 
also reported to be successful after failed treatment with 
steroids and chemotherapy.20 
 There has been widespread use of steroids to 
shrink the immature hemangiomatous tissues since 
Touloukian first reported success in an 8tmonthtold 
infant.21 Dosages of prednisolone used for treatment 
have been between 2 to 10 mg/kg/day. Successful imt
provement with steroid therapy was reported in many 
case reports.3,22t27 Steroid treatment results in dramatic 
shrinkage of the hemangioma in one third of cases, but 
a third may prove unresponsive to steroids and can be 
treated with interferon alfat2a.3 However, investigators 
in many studies have argued that the side effects of high 
doses of steroids and their complications were serious, 
and also showed treatment failure with disappointing 
results.28t33 
Interferontalpha therapy has also been used as a 
component of medical management.34,35 Successful 
treatment with cyclophosphamide after failure of stet
roid therapy was also reported.29 There is considerable 
optimism about the development of potent antitangiot
genic drugs. The angiogenesis inhibitor AGMt1470 
was able to inhibit growth of hemangioendothelioma 
in a mouse model.36 
In summary, we report that hightdose prednisot
lone therapy has improved the symptoms of infantile 
hemangioendothelioma in a female infant and comt
pletely resolved the hepatic hemangioendothelioma 
on followtup.
Figure 2. Post-contrast CT of the abdomen showing a marked 
reduction of nodule size.
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